Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma, Follicular

Explore clinical trials studying Adenocarcinoma, Follicular. Study availability and eligibility vary by location and protocol.

53 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma, Follicular trial results

Completed

Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

NCT00104871

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +17 more
Locations
  • University of Colorado at Denver Health Sciences Center Aurora, Colorado, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View Trial Details
Completed

Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131

NCT00085293

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +18 more
Locations
  • University of Colorado at Denver Aurora, Colorado, United States
  • Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer

NCT01811212

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +28 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View Trial Details
Completed

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

NCT00295763

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +12 more
Locations
  • University of Colorado Health Sciences Centre Aurora, Colorado, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Ohio State University Columbus, Ohio, United States
  • MD Anderson Cancer Centre Houston, Texas, United States
View Trial Details

Related conditions